Exelixis (EXEL) Revenue (2010 - 2026)
Exelixis (EXEL) posted quarterly Revenue of $610.8 million for Q2 2026, up 9.97% year-over-year from $555.4 million in Q2 2025, and up 2.03% quarter-over-quarter from $598.7 million in Q1 2026.
Exelixis (EXEL) Revenue (2010 - 2026) Analysis & Trends
Exelixis' Revenue history runs 17 years deep, the most recent figure standing at $610.8 million for Q2 2026.
- In Q2 2026, Revenue rose 9.97% year-over-year to $610.8 million; the TTM figure through Apr 2026 stood at $2.4 billion (up 3.33% YoY), while the FY2026 annual figure was $2.3 billion, up 6.98% from the prior year.
- Revenue for Q2 2026 stood at $610.8 million, up from $598.7 million in the prior quarter.
- The five-year high for Revenue was $637.2 million in Q2 2024, with the low at $356.0 million in Q2 2022.
- The 5-year median for Revenue is $479.7 million (2023), against an average of $502.4 million.
- The sharpest annual moves came in 2024 and 2025: Revenue surged 35.61% in 2024, then fell 10.82% in 2025.
- Exelixis' Revenue stood at $423.9 million in 2022, then increased by 13.15% to $479.7 million in 2023, then climbed by 12.49% to $539.5 million in 2024, then climbed by 10.79% to $597.8 million in 2025, then increased by 2.18% to $610.8 million in 2026.
- Business Quant data shows EXEL's Revenue at $610.8 million in Q2 2026, $598.7 million in Q1 2026, and $597.8 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Exelixis | 12.75 Bn | 11.91 Bn | 608.03 Mn | 628.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | 628.69 Mn |
| Apr 3, 2026 | 610.81 Mn |
| Jan 2, 2026 | 598.66 Mn |
| Oct 3, 2025 | 597.76 Mn |
| Jul 4, 2025 | 568.26 Mn |
| Apr 4, 2025 | 555.45 Mn |
| Jan 3, 2025 | 566.76 Mn |
| Sep 27, 2024 | 539.54 Mn |
| Jun 28, 2024 | 637.18 Mn |
| Mar 29, 2024 | 425.23 Mn |
| Dec 29, 2023 | 479.65 Mn |
| Sep 29, 2023 | 471.92 Mn |
| Jun 30, 2023 | 469.85 Mn |
| Mar 31, 2023 | 408.79 Mn |
| Dec 30, 2022 | 423.92 Mn |
| Sep 30, 2022 | 411.74 Mn |
| Jul 1, 2022 | 419.43 Mn |
| Apr 1, 2022 | 355.98 Mn |
| Oct 1, 2021 | 328.42 Mn |
| Jul 2, 2021 | 385.18 Mn |